Article

A patient with non-small cell lung cancer presenting with headaches and change in mental status


 

A 79-year-old woman with a history of non-small cell carcinoma of the right lung, stage IIB (T3, N0, M0) was treated with definitive chemoradiation, with 6,480 cGy given to the right upper lobe and mediastinum with concomitant chemotherapy. On a follow-up visit 3 months later, PET-CT imaging showed remarkable improvement in her tumor response, with evidence of tumor regression on CT. The patient was in her normal state of health until 4 months later, when she began complaining of headaches and her son noted that she was disoriented, confused, mildly aphasic, and unstable.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Postop Radiation Does Little for Elderly Lung Cancer Patients
MDedge Hematology and Oncology
NICE Decision on Erlotinib to Hinge on Cost Comparison With Gefitinib
MDedge Hematology and Oncology
FDA Tracks Fake Avastin to Foreign Supply Distributed in U.S.
MDedge Hematology and Oncology
VEGF-Targeting Cancer Drugs Raise Risk of Fatal Side Effects
MDedge Hematology and Oncology
Exposure to Diesel Exhaust Tied to More Lung Cancer Deaths
MDedge Hematology and Oncology
NCCN Reaffirms Lung Cancer Screening of Heavy Smokers
MDedge Hematology and Oncology
Ten Biomarkers May Aid Lung Cancer Detection
MDedge Hematology and Oncology
The Role of Spirituality and Religious Coping in the Quality of Life of Patients With Advanced Cancer Receiving Palliative Radiation Therapy
MDedge Hematology and Oncology
Palonosetron Plus 1-Day Dexamethasone for the Prevention of Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy: Effect of Established Risk Factors on Treatment Outcome in a Phase III Trial
MDedge Hematology and Oncology
Screening for lung cancer
MDedge Hematology and Oncology